Provided by Tiger Trade Technology Pte. Ltd.

Windtree Therapeutics, Inc.

0.0237
-0.0013-5.20%
Volume:88.86K
Turnover:2.20K
Market Cap:695.22K
PE:0.00
High:0.0250
Open:0.0244
Low:0.0224
Close:0.0250
52wk High:1.86
52wk Low:0.0071
Shares:29.33M
Float Shares:28.66M
Volume Ratio:0.45
T/O Rate:0.31%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.3803
EPS(LYR):-104.3493
ROE:-412.90%
ROA:-42.39%
PB:-0.06
PE(LYR):0.00

Loading ...

Windtree Therapeutics delays annual report filing, targets April 15 submission

Reuters
·
Apr 01

CommLoan and Windtree Therapeutics near definitive agreement on proposed reverse merger

Reuters
·
Mar 17

Windtree Therapeutics President and COO Eric Curtis Resigns

Reuters
·
Jan 08

Windtree Therapeutics Sells Cardiovascular Drug Candidates to Seismic Pharmaceutical Holdings

Reuters
·
Dec 23, 2025

Windtree Therapeutics Announces the Sale of Its Cardiovascular Biotech Pipeline Drug Candidates

THOMSON REUTERS
·
Dec 23, 2025

Windtree Therapeutics Inc - to Receive $700K Contingent on $10M Financing Round

THOMSON REUTERS
·
Dec 23, 2025

BRIEF-Windtree Therapeutics Announces It Has Signed A Letter Of Intent To Acquire Commloan

Reuters
·
Dec 03, 2025

Windtree Therapeutics Inc - Provides Bridge Financing to Commloan

THOMSON REUTERS
·
Dec 03, 2025

Windtree Therapeutics Announces It Has Signed a Letter of Intent to Acquire Commloan, Inc. a Revenue Generating Company in the Rapidly Growing Fintech Space

THOMSON REUTERS
·
Dec 03, 2025

Windtree Therapeutics Inc - Commloan to Become Subsidiary of Windtree

THOMSON REUTERS
·
Dec 03, 2025

Windtree Therapeutics Secures $857,000 Convertible Note Financing for CommLoan Acquisition

Reuters
·
Dec 03, 2025

Windtree Therapeutics May Receive Up to $78.9 Million in License Agreement Payments

Reuters
·
Nov 17, 2025

Windtree Therapeutics Inc - License Agreement Could Pay up to $78.9 Mln

THOMSON REUTERS
·
Nov 17, 2025

Windtree Therapeutics Announces It May Receive License Agreement Payments From Its Licensee for Renewed Acute Pulmonary Development by the Licensee

THOMSON REUTERS
·
Nov 17, 2025

Windtree Therapeutics Delays Quarterly Financial Report Filing

Reuters
·
Nov 15, 2025

Windtree Therapeutics Secures $1.6 Million in Senior Convertible Promissory Notes Due 2026 in New Financing Agreement

Reuters
·
Oct 17, 2025

Windtree Therapeutics Settles Dispute Over Houston Property, Receives $750,000 from Escrow

Reuters
·
Oct 07, 2025